Gastric inhibitory polypeptide links overnutrition to obesity

Gut

Volumn 52, Issue 3, 2003, Pages 319-320

  Ballinger, A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; GASTRIC INHIBITORY POLYPEPTIDE; INSULIN;

DUODENUM; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; NONHUMAN; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0037373077     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.3.319     Document Type: Short Survey

References (15)

1. Meier JJ, Mauck MA, Schmidt WE, et al, Gastric inhibitory polypeptide: the neglected incretin revisited. Reg Pept 2002;107:1-13.
2. Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002;8:738-42.
3. Kosaka T, Lim RKS. Demonstration of the humoral agent in fat inhibition on gastric secretion. Proc Soc Exp Biol Med 1930;27:890-1.
4. Brown JC, Mutt V, Pederson PRA. Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol 1970;209:57-64.
5. Polak JM, Bloom SR, Kuzio M, et al, Cellular localisation of gastric inhibitory polypeptide in the duodenum and jejunum. Gut 1973;14:284-8.
6. Buffa B, Polak JM, Pearse AGE, et al. Identification of the intestinal cell storing gastric inhibitory polypeptide. Histochemistry 1975;43:249-55.
7. Brown JC, Dryburgh JR. A gastric inhibitory polypeptide II. The complete amino acid sequence. Can J Biochem 1971;49:867-72.
8. Elrick H, Stimmler L, Hlad CJ, et al, Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 1964;24:1076-82.
9. McIntyre N, Holdsworth CD, Turner DS. Intestinal factors in the control of insulin secretion. J Clin Endocrinol 1965;25:1317-24.
10. Pederson RA, Schubert HE, Brown JC. Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes 1975;24:1050-6.
11. th 1976;2:568-70.
12. Nauck MA, Bartels E, Ørskov C, et al, Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 (7-36 amide) infused at near- physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects. Digestion 1992;52:214-21.
13. Miyawaki K, Yamada Y, Yano H, et al, Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A 1999;96:14843-7.
14. Beck B, Max JP. Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat. Regul Pept 1983;7:3-8.
15. Oben J, Morgan L, Fletcher J, et al Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1 (7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 1991;130:267-72.